Beloteca, Inc. Opens Product Development Laboratory In San Diego, California
According to company officials, “Beloteca's primary focus is to develop and obtain regulatory approval for sterile pharmaceutical products with an emphasis on generics and 505(b)(2) reformulations. We target niche and difficult to manufacture products.”
"This new laboratory helps Beloteca achieve its mission of developing multiple products per year," said Fred Defesche, CEO of Beloteca, Inc. "It also allows Beloteca to take greater control over project timelines and the development process."
"The new laboratory establishes Beloteca's in-house product development capabilities allowing the evaluation of development projects prior to initiating full development creating a more nimble and aggressive approach to project selection. Additionally, the new laboratory will be used for many of Beloteca's analytical and formulation development activities enabling Beloteca to develop many of its products in house," stated Dorla Mirejovsky, CFO of Beloteca.
Toyota Industries Compressor Parts America Expands Pendergrass, Georgia, Production Factory
Eastern Wholesale Fence Plans Manufacturing Center of Excellence in Salisbury, North Carolina
Continental Tire the Americas Eyes Expansion at Factory Complex in Lancaster County, South Carolina
Why are Foreign Trade Zones Making a Comeback?
The New Normal in the Automotive Supply Chain
2020 Auto/Aero Site Guide
34th Annual Corporate Survey & the 16th Annual Consultants Survey
Infrastructure Investment as an Economic Stimulus Tool
2019 Top States for Doing Business: Georgia Ranks #1 Sixth Year in a Row
Nondisclosure Agreements Best Practices When Negotiating Incentives